Načítá se...
COX-2-PGE(2)-EPs in gynecological cancers
PURPOSE: Nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors (COXibs) inhibit the progression of endometrial cancer, ovarian cancer and cervical cancer. However, concerning the adverse effects of NSAIDs and COXibs, it is still urgent and necessary to explore novel and specif...
Uloženo v:
| Vydáno v: | Arch Gynecol Obstet |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Berlin Heidelberg
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7246249/ https://ncbi.nlm.nih.gov/pubmed/32363546 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00404-020-05559-6 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|